Management of cutaneous lupus erythematosus

Keyphrases

• Cutaneous Lupus Erythematosus 100%
• Severe Disease 66%
• Dapsone 66%
• Rituximab 33%
• Prednisone 33%
• Methotrexate 33%
• Mycophenolate Mofetil 33%
• Skin Diseases 33%
• Treatment Strategy 33%
• Response to Therapy 33%
• Intravenous Immunoglobulin (IVIg) 33%
• Long-term Treatment 33%
• Retinoids 33%
• Thalidomide 33%
• Moderate Disease 33%
• Quinacrine 33%
• Chloroquine 33%
• Calcineurin Inhibitors 33%
• Steroid-sparing 33%
• Hydroxychloroquine 33%
• Mild Disease 33%
• Refractory Disease 33%
• Photoprotection 33%
• Belimumab 33%
• Lenalidomide 33%
• Intralesional Steroids 33%
• Topical Glucocorticoids 33%
• Anifrolumab 33%

Medicine and Dentistry

• Mycophenolate Mofetil 33%
• Anifrolumab 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Mycophenolate Mofetil 33%